Amarin Corporation

Amarin Corporation Inventory

The Inventory of Amarin Corporation (AMRN) as of Nov 19, 2026 is 195.91 M USD. In the previous year, Inventory was 166.05 M USD — a change of 17.98% (higher).

Inventory

195.91 MUSD

YoY

17.98%

Last updated:

Inventory of Amarin Corporation is 2025 195.91 M USD. Inventory of Amarin Corporation was 2024 166.05 M USD. It decreases by 17.98% higher compared to the previous year.

The Amarin Corporation Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
57.80 M USD
Jan 1, 2019
76.77 M USD
Jan 1, 2020
188.86 M USD
Jan 1, 2021
234.68 M USD
Jan 1, 2022
228.73 M USD
Jan 1, 2023
258.62 M USD
Jan 1, 2024
166.05 M USD
Jan 1, 2025
195.91 M USD
The Amarin Corporation Inventory history
YEARInventoryYoY
195.91 MUSD+17.98%
166.05 MUSD-35.79%
258.62 MUSD+13.07%
228.73 MUSD-2.53%
234.68 MUSD+24.26%
188.86 MUSD+146.02%
76.77 MUSD+32.81%
57.80 MUSD+91.02%
30.26 MUSD+47.56%
20.51 MUSD+8.02%
18.99 MUSD+38.24%
13.73 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amarin Corporation Stock analysis

What does Amarin Corporation do? Amarin Corporation PLC generates revenue primarily through the sale of Vascepa (icosapent ethyl) capsules, approved by the FDA for reducing triglyceride levels in patients with severe hypertriglyceridemia. The company sells Vascepa to wholesalers, regional wholesalers, and specialty pharmacy providers, collectively referred to as distributors, who then resell the product to retail pharmacies for patient and healthcare provider use. The MARINE indication, derived from the MARINE study, is the key approved use driving sales in the cardiovascular health segment. Amarin's commercial strategy centers on the Vascepa segment, focusing on the development and commercialization of this therapeutic. The firm's lead product, Vascepa, is positioned as an adjunct to diet for treating severe hypertriglyceridemia, targeting healthcare providers and patients through a distribution network of wholesalers and specialty pharmacies. This model ensures Vascepa reaches retail pharmacies where it is dispensed to end users. Amarin Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Amarin Corporation stock

Inventory of Amarin Corporation is 195.91 M USD in 2025.

Inventory of Amarin Corporation changed from 166.05 M USD to 195.91 M USD, representing a 17.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Amarin Corporation since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Amarin Corporation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Amarin Corporation

All Key Metrics — Amarin Corporation